Prothena Corporation Public (NASDAQ: PRTA) net income
Prothena Corporation Public reported a net loss of $244.1m for fiscal 2025; in fiscal 2024 it reported a net loss of $122.3m. Earnings per share were −$4.53.
Prothena Corporation Public's best year of the last 10 was fiscal 2021. It reported a loss in 9 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$244.1m | — | −2,520.6% | −$4.53 |
| 2024 | −$122.3m | — | −90.5% | −$2.27 |
| 2023 | −$147.0m | — | −160.9% | −$2.76 |
| 2022 | −$116.9m | −274.6% | −217.0% | −$2.47 |
| 2021 | $67.0m | — | 33.4% | $1.51 |
| 2020 | −$111.1m | — | −13,029.8% | −$2.78 |
| 2019 | −$77.7m | — | −9,542.6% | −$1.95 |
| 2018 | −$155.6m | — | −16,297.9% | — |
| 2017 | −$153.2m | — | −556.8% | — |
| 2016 | −$160.1m | — | −15,176.1% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Prothena Corporation Public net income compared with its sector
By net income for its latest fiscal year, Prothena Corporation Public ranks 432nd of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Prothena Corporation Public, −2,520.6%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 430th | LivaNova | −$242.5m | −17.5% |
| 431st | Alumis | −$243.3m | −1,011.7% |
| 432nd | Prothena Corporation Public | −$244.1m | −2,520.6% |
| 433rd | Sana Biotechnology | −$244.2m | — |
| 434th | Tempus AI | −$245.0m | −19.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Prothena Corporation Public
- How much did Prothena Corporation Public earn in fiscal 2025?
- Prothena Corporation Public reported a net loss of $244.1m for fiscal 2025. In fiscal 2024 it reported a net loss of $122.3m.
- What are the earnings per share of Prothena Corporation Public?
- They were −$4.53 in fiscal 2025, compared with −$2.27 in fiscal 2024.
- What was the most profitable year for Prothena Corporation Public?
- Of its last 10 fiscal years, fiscal 2021, with $67.0m.
- Where does Prothena Corporation Public rank in its sector by net income?
- It ranks 432nd of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Prothena Corporation Public come from?
- From the annual report (Form 10-K) that Prothena Corporation Public files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Prothena Corporation Public files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Prothena Corporation Public: the Prothena Corporation Public page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.